Evolent Health Company Top Insiders

EVH Stock  USD 4.02  0.07  1.77%   
Evolent Health's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Evolent Health suggests that almost all insiders are extremely bullish. Evolent Health employs about 4.5 K people. The company is managed by 39 executives with a total tenure of roughly 156 years, averaging almost 4.0 years of service per executive, having 115.38 employees per reported executive.
Seth Blackley  CEO
Chief Executive Officer, Co-Founder, Director
Frank Williams  Chairman
Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2025-03-06Seth BlackleyAcquired 55225 @ 9.01View
2025-03-04Brendan B SpringstubbAcquired 5000 @ 8.75View
Monitoring Evolent Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Evolent Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Evolent Health's future performance. Based on our forecasts, it is anticipated that Evolent will maintain a workforce of under 4500 employees by February 2026.
 
Yuan Drop
 
Covid

Evolent Health's latest congressional trading

Congressional trading in companies like Evolent Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Evolent Health by those in governmental positions are based on the same information available to the general public.
2020-05-29Representative Greg GianforteAcquired $50K to $100KVerify

Evolent Health Management Team Effectiveness

The current Return On Tangible Assets is estimated to decrease to -0.08. The current Return On Capital Employed is estimated to decrease to -0.02. As of now, Evolent Health's Other Current Assets are increasing as compared to previous years. The Evolent Health's current Intangible Assets is estimated to increase to about 821.3 M, while Non Currrent Assets Other are projected to decrease to under 25.9 M. Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.
The current Common Stock Shares Outstanding is estimated to decrease to about 77.9 M. The current Net Loss is estimated to decrease to about (88.3 M)
The majority of Evolent Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolent Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolent Health. Please pay attention to any change in the institutional holdings of Evolent Health as this could imply that something significant has changed or is about to change at the company. Please note that on May 29, 2020, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Evolent Health's common stock.
 
Shares in Circulation  
First Issued
2013-12-31
Previous Quarter
115.9 M
Current Value
114.1 M
Avarage Shares Outstanding
77.8 M
Quarterly Volatility
27.3 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Evolent Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Evolent Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Evolent Health Workforce Comparison

Evolent Health is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 13,681. Evolent Health totals roughly 4,500 in number of employees claiming about 33% of equities under Health Care industry.
The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average.

Evolent Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolent Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolent Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Evolent Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-09-01
4.0
4
1
 160,772 
 2,567 
2025-03-01
2.0
24
12
 1,130,494 
 224,838 
2024-09-01
0.4
6
15
 234,594 
 519,759 
2024-03-01
0.8462
11
13
 391,263 
 206,018 
2023-12-01
0.25
2
8
 283,000 
 433,490 
2023-09-01
0.2857
2
7
 13,386 
 50,482 
2023-06-01
0.6522
15
23
 481,432 
 903,009 
2023-03-01
0.5152
17
33
 1,546,302 
 1,959,501 
2022-12-01
0.3
3
10
 295,000 
 590,000 
2022-09-01
0.2727
3
11
 217,247 
 509,955 
2022-06-01
9.0
9
1
 50,076 
 3,860 
2022-03-01
0.4583
11
24
 836,298 
 966,247 
2021-12-01
0.3846
5
13
 183,405 
 390,000 
2021-09-01
0.4762
20
42
 175,318 
 402,716 
2021-06-01
1.1818
13
11
 119,417 
 125,052 
2021-03-01
7.0
7
1
 164,590 
 0.00 
2020-09-01
0.5
1
2
 10,000 
 20,000 
2020-06-01
1.3333
8
6
 268,114 
 99,530 
2020-03-01
6.0
6
1
 530,219 
 0.00 
2019-09-01
0.4
2
5
 22,200 
 80,222 
2018-09-01
0.3103
9
29
 245,440 
 735,559 
2018-06-01
0.5625
9
16
 58,672 
 3,189,979 
2018-03-01
6.0
12
2
 2,486,174 
 4,812,898 
2017-09-01
0.3077
4
13
 27,700 
 114,507 
2017-06-01
0.403
27
67
 8,034,433 
 20,455,695 
2017-03-01
0.6071
17
28
 4,713,444 
 11,742,278 
2016-09-01
0.5238
11
21
 2,037,829 
 10,427,023 
2016-06-01
1.0
1
1
 8,183 
 0.00 
2015-12-01
2.0
2
1
 12,954 
 0.00 
2015-06-01
0.0227
1
44
 2,000 
 13,768,760 

Evolent Health Notable Stakeholders

An Evolent Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Evolent Health often face trade-offs trying to please all of them. Evolent Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Evolent Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dan McCarthyCEO PresidentProfile
Seth BlackleyChief Executive Officer, Co-Founder, DirectorProfile
Frank WilliamsCo-Founder, CEO, Director and Chairman of Nominating and Governance CommitteeProfile
Nicholas McGraneExecutive Vice President of Corporate PerformanceProfile
Scott PritchardPresident SuiteProfile
John JohnsonChief Financial OfficerProfile
Thomas PetersonChief Operating OfficerProfile
Steve TutewohlChief Operating OfficerProfile
Bridget DuffyIndependent DirectorProfile
Bruce FeltIndependent DirectorProfile
Cheryl ScottLead Independent DirectorProfile
David FarnerDirectorProfile
Diane HolderDirectorProfile
Michael DAmatoIndependent DirectorProfile
Kim KeckIndependent DirectorProfile
Jonathan JDGeneral OfficerProfile
Geoff McHughChief OfficerProfile
Katie CookChief OfficerProfile
Robert CruzChief OfficerProfile
John MDChief OfficerProfile
Tunde SotundeIndependent DirectorProfile
Andrew MDChief AdvisorProfile
MAAA FSAChief OfficerProfile
Emily RaffertyExecutive SuccessProfile
M DuffyIndependent DirectorProfile
John WayChief SuiteProfile
Craig BarbaroshIndependent DirectorProfile
Jordan SilvergleidChief OfficerProfile
Jonathan WeinbergGeneral CounselProfile
Aammaad ShamsInterim Principal Accounting Officer and Corporate ControllerProfile
Jessica SomersSr DevelProfile
Seth FrankVice RelationsProfile
Mark MannionSenior FinanceProfile
Mario RamosChief OfficerProfile
Peter GruaIndependent DirectorProfile
David LimChief OfficerProfile
Kali BeyahChief OfficerProfile
Jessica WhiteChief OfficerProfile
MPH MDChief OfficerProfile
String symbol = request.getParameter("s");

About Evolent Health Management Performance

The success or failure of an entity such as Evolent Health often depends on how effective the management is. Evolent Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Evolent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Evolent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.08)(0.08)
Return On Capital Employed(0.02)(0.02)
Return On Assets(0.02)(0.02)
Return On Equity(0.07)(0.07)

Evolent Health Workforce Analysis

Traditionally, organizations such as Evolent Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Evolent Health within its industry.

Evolent Health Manpower Efficiency

Return on Evolent Health Manpower

Revenue Per Employee567.7K
Revenue Per Executive65.5M
Net Loss Per Employee13.7K
Net Loss Per Executive1.6M

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital